{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:27:16Z","timestamp":1791358036491,"version":"4.3.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.oooo.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:25:06Z","timestamp":1757859906000},"page":"170-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Orofacial adverse events associated with immune checkpoint inhibitors: using a large real-world dataset"],"prefix":"10.1016","volume":"141","author":[{"given":"Stella O.","family":"Oyewole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-9469","authenticated-orcid":false,"given":"Adepitan A.","family":"Owosho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12935-021-02299-8","article-title":"Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies","volume":"21","author":"Yang","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12943-024-02179-5","article-title":"Current trends in sensitizing immune checkpoint inhibitors for cancer treatment","volume":"23","author":"Wei","year":"2024","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13046-019-1266-0","article-title":"Advances in cancer immunotherapy 2019 - latest trends","volume":"38","author":"Kruger","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"23","key":"10.1016\/j.oooo.2025.09.006_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312848","article-title":"Tumor microenvironment drives the cross-talk between co-stimulatory and inhibitory molecules in tumor-infiltrating lymphocytes: implications for optimizing immunotherapy outcomes","volume":"25","author":"Franzese","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0005","doi-asserted-by":"crossref","first-page":"ltab016","DOI":"10.1093\/immadv\/ltab016","article-title":"Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers","volume":"1","author":"Harrison","year":"2021","journal-title":"Immunother Adv"},{"key":"10.1016\/j.oooo.2025.09.006_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8(+) T cell exhaustion in cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.oooo.2025.09.006_bib0007","article-title":"Exhausted CD8+T cells in the tumor immune microenvironment: new pathways to therapy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.oooo.2025.09.006_bib0008","first-page":"451","article-title":"Immune checkpoint inhibitors: breakthroughs in cancer treatment","volume":"21","author":"Kong","year":"2024","journal-title":"Cancer Biol Med"},{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13045-022-01325-0","article-title":"Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts","volume":"15","author":"Wang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.oooo.2025.09.006_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40425-015-0078-9","article-title":"Pembrolizumab","volume":"3","author":"Khoja","year":"2015","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.oooo.2025.09.006_bib0011","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.oooo.2025.09.006_bib0012","first-page":"1165","article-title":"adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.36401\/JIPO-23-14","article-title":"Oral toxicities associated with immune checkpoint inhibitors: meta-analyses of clinical trials","volume":"7","author":"Srivastava","year":"2024","journal-title":"J Immunother Precis Oncol"},{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0014","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.oooo.2022.12.013","article-title":"Osteonecrosis of the jaw associated with pembrolizumab","volume":"136","author":"Pennings","year":"2023","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"10","key":"10.1016\/j.oooo.2025.09.006_bib0015","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1111\/jdv.14284","article-title":"Oral lichenoid reactions associated with anti-PD-1\/PD-L1 therapies: clinicopathological findings","volume":"31","author":"Sibaud","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2025.09.006_bib0016","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.oraloncology.2016.09.011","article-title":"Squamous cell carcinoma associated with chronic graft versus host disease-like\/lichen planus-like lesion of the oral cavity in a patient managed for metastatic melanoma with a PD-1 inhibitor pembrolizumab","volume":"63","author":"Owosho","year":"2016","journal-title":"Oral Oncol"},{"issue":"12","key":"10.1016\/j.oooo.2025.09.006_bib0017","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.oraloncology.2015.08.014","article-title":"Osteonecrosis of the jaw a new complication related to Ipilimumab","volume":"51","author":"Owosho","year":"2015","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/odi.13964","article-title":"Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors","volume":"28","author":"Klein","year":"2022","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.oooo.2025.09.006_bib0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.annder.2022.11.012","article-title":"Oral mucosal toxicities induced by immune checkpoint inhibitors: clinical features and algorithm management","volume":"150","author":"Vigarios","year":"2023","journal-title":"Ann Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.oooo.2025.09.006_bib0020","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/odi.14000","article-title":"Sicca syndrome associated with immune checkpoint inhibitor therapy","volume":"28","author":"Harris","year":"2022","journal-title":"Oral Dis"},{"issue":"11","key":"10.1016\/j.oooo.2025.09.006_bib0021","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/cncr.33436","article-title":"Oral side effects of immune checkpoint inhibitor therapy (ICIT): an analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana-Farber Cancer Institute, 2011 to 2019","volume":"127","author":"Xu","year":"2021","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.oooo.2025.09.006_bib0022","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/hed.27646","article-title":"Orofacial complications from immune checkpoint inhibitors: a retrospective analysis from two academic medical centers","volume":"46","author":"Al-Eryani","year":"2024","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.oooo.2025.09.006_bib0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJMoa2415434","article-title":"Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer","volume":"393","author":"Uppaluri","year":"2025","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.oooo.2025.09.006_bib0024","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0000000000011795","article-title":"Neurologic adverse events of immune checkpoint inhibitors: a systematic review","volume":"96","author":"Marini","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.oooo.2025.09.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002890","article-title":"Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors","volume":"9","author":"Guidon","year":"2021","journal-title":"J Immunother Cancer"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440325012039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440325012039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T20:21:55Z","timestamp":1767471715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440325012039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2212440325012039"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2025.09.006","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orofacial adverse events associated with immune checkpoint inhibitors: using a large real-world dataset","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}